Home/Pipeline/Keverprazan Hydrochloride

Keverprazan Hydrochloride

Acid-related Diseases (e.g., GERD)

Phase III / NDAActiveN/A

Key Facts

Indication
Acid-related Diseases (e.g., GERD)
Phase
Phase III / NDA
Status
Active
Company

About Fosun Pharma

Fosun Pharma's mission is to be the global leading integrator of pharmaceutical and healthcare innovation, delivering 'Better Health for Families Worldwide.' The company has achieved significant milestones, including China's first approved CAR-T cell therapy (Yi Kai Da), a leading biosimilar portfolio, and the WHO-recommended antimalarial Artesun®. Its strategy combines independent R&D with aggressive in-licensing and global partnerships to build a diversified portfolio across therapeutics, vaccines, and diagnostics, supported by a vast commercial network through its stake in Sinopharm.

View full company profile